Mostrar el registro sencillo del ítem

Recommendations for reducing the risk of cannabis use-related adverse psychosis outcomes: a public mental health-oriented evidence review

dc.creatorFischer, Benediktes_ES
dc.creatorHall, Waynees_ES
dc.creatorFidalgo, Thiago M.es_ES
dc.creatorHoch, Evaes_ES
dc.creatorFoll, Bernard Lees_ES
dc.creatorMedina-Mora, Maria Elenaes_ES
dc.creatorReimer, Jenses_ES
dc.creatorTibbo, Philip G.es_ES
dc.creatorJutras-Aswad, Didieres_ES
dc.date2023
dc.date.accessioned2025-04-15T20:03:18Z
dc.date.available2025-04-15T20:03:18Z
dc.date.issued2023
dc.identifierJC63DIEP23es_ES
dc.identifier.issn1550-4263
dc.identifier.urihttp://repositorio.inprf.gob.mx/handle/123456789/8317
dc.identifier.urihttps://doi.org/10.1080/15504263.2023.2226588
dc.descriptionObjective: Cannabis use is increasingly normalized; psychosis is a major adverse health outcome. We reviewed evidence on cannabis use-related risk factors for psychosis outcomes at different stages toward recommendations for risk reduction by individuals involved in cannabis use. Methods: We searched primary databases for pertinent literature/data 2016 onward, principally relying on reviews and high-quality studies which were narratively summarized and quality-graded; recommendations were developed by international expert consensus. Results: Genetic risks, and mental health/substance use problem histories elevate the risks for cannabis-related psychosis. Early age-of-use-onset, frequency-of-use, product composition (i.e., THC potency), use mode and other substance co-use all influence psychosis risks; the protective effects of CBD are uncertain. Continuous cannabis use may adversely affect psychosis-related treatment and medication effects. Risk factor combinations further amplify the odds of adverse psychosis outcomes. Conclusions: Reductions in the identified cannabis-related risks factors—short of abstinence—may decrease risks of related adverse psychosis outcomes, and thereby protect cannabis users’ health.es_ES
dc.formatPDFes_ES
dc.language.isoenges_ES
dc.publisherHaworth Medical Presses_ES
dc.relation19(2-3):71-96
dc.rightsAcceso Cerradoes_ES
dc.titleRecommendations for reducing the risk of cannabis use-related adverse psychosis outcomes: a public mental health-oriented evidence reviewes_ES
dc.typeArtículoes_ES
dc.contributor.affiliationCentre for Applied Research in Mental Health and Addiction, Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada
dc.contributor.emailbfischer@sfu.ca (Benedikt Fischer)
dc.relation.jnabreviadoJ DUAL DIAGN
dc.relation.journalJournal of Dual Diagnosis
dc.identifier.placeEstados Unidos
dc.date.published2023
dc.identifier.organizacionInstituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
dc.identifier.eissn1550-4271
dc.identifier.doi10.1080/15504263.2023.2226588
dc.subject.kwCannabis
dc.subject.kwPsychosis
dc.subject.kwRisk factors
dc.subject.kwEpidemiology
dc.subject.kwMental health
dc.subject.kwPrevention
dc.subject.kwFirst episode
dc.subject.kwTreatment
dc.subject.kwHealth outcomes
dc.subject.kwRecommendations


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem